Skip to main content

HYL · Hyloris Pharmaceuticals · Debt

4.0800 EUR -0.1200 (-2.86%) At close · Oct 5
Market Cap
124.60M EUR
Shares
28.00M

Debt Profile

Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.

Reported debt balances

Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.

Reported balanceAs ofAmountSource
Noncurrent long-term borrowings 2025-12-31 EUR 1,246,000 ESEF Annual Report filed 2026-05-12
Short-term borrowings 2025-12-31 EUR 364,000 ESEF Annual Report filed 2026-05-12
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.

Covenants

Covenant terms have not yet been verified for this profile.

The balance figures do not establish whether covenants apply or whether the company complies with them.

Loans, facilities and notes

The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.